PNC Financial Services Group
IMNM icon

PNC Financial Services Group’s Immunome IMNM Stock Holding History

PNC Financial Services Group’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.4K Buy
916
+261
+40% +$5.58K ﹤0.01% 3799
2026
Q1 		$14.3K Sell
655
-205
-24% -$4.56K ﹤0.01% 3826
2025
Q4 		$18.5K Buy
860
+309
+56% +$5.42K ﹤0.01% 3706
2025
Q3 		$6.45K Buy
551
+198
+56% +$1.97K ﹤0.01% 4117
2025
Q2 		$3.28K Hold
353
– – ﹤0.01% 4264
2025
Q1 		$2.38K Hold
353
– – ﹤0.01% 4295
2024
Q4 		$3.75K Hold
353
– – ﹤0.01% 4115
2024
Q3 		$5.16K Buy
+353
New +$5.02K ﹤0.01% 4030

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

PNC Financial Services Group's IMNM Position: Q2 2026 in Review

PNC Financial Services Group increased its Immunome (IMNM) stake by 40% in Q2 2026, buying an estimated $5.58K and bringing the position to 916 shares worth $19.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3799.

PNC Financial Services Group first reported a position in IMNM in Q3 2024 and has held it in 8 quarters since. 202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • PNC Financial Services Group held 916 shares of Immunome worth $19.4K as of Q2 2026.
  • PNC Financial Services Group bought 261 Immunome shares in Q2 2026, an estimated $5.58K.
  • Immunome made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3799 holding.
  • PNC Financial Services Group first reported a position in Immunome in Q3 2024 and has held it in 8 quarters since.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.